Affiliation:
1. Department of General Surgery, Tianjin Fifth Central Hospital, Tianjin, 300450, China
Abstract
Breast cancer (BC) is a highly prevalent aggressive malignancy in women worldwide, and the search for key targets in its pathogenesis is a focus of research. Long non-coding RNAs (lncRNAs) play an important role in many cancers, including breast cancer. This study aimed to investigate
the role of lncRNA SNHG9 in BC. The expression of SNHG9 in BC cells was found to be higher than that of human mammary epithelium. SNHG9 was found to inhibit the proliferation, migration, and invasion of cells and promote apoptosis. It was also found that SNHG9 regulates the miR-326/Wnt5a/β-catenin
axis to promote the development of BC. Dual luciferase reporter and RNA pull-down assays confirmed the interaction between SNHG9, Wnt5a, and miR-326. Western blot analysis indicated that the expression of Wnt5a, β-catenin, c-myc, and cyclin D1 decreased significantly after the
silencing of SNHG9 and the overexpression of miR-326. On the contrary, Wnt5a, β-catenin, c-myc, and cyclin D1 proteins were significantly up-regulated after inhibiting miR-326 expression. These findings suggest that SNHG9 is a promising target for BC therapy.
Publisher
American Scientific Publishers
Subject
Pharmaceutical Science,General Materials Science,Biomedical Engineering,Medicine (miscellaneous),Bioengineering
Reference38 articles.
1. Causes of cancer in the world: Comparative risk assessment of nine behavioral and environmental risk factors;Ansari;Cureus Journal of Medical Science,2022
2. Gold-nanoparticle-conjugated citrate inhibits tumor necrosis factor-’ expression via suppression of nuclear factor kappa B (NF-KB) activation in breast cancer cells;Aljohani;Journal of Biomedical Nanotechnology,2022
3. Breast cancer in Turkey; an analysis of 20.000 patients with breast cancer;Ozmen;European Journal of Breast Health,2019
4. Musculoskeletal pain and the prevalence of rheumatoid arthritis in breast cancer patients during cancer treatment: A retrospective study;Kim;Journal of Breast Cancer,2022
5. Surgical resection and outcome of synchronous and metachronous primary lung cancer in breast cancer patients;Shoji;Anticancer Research,2017